Metabolic and inflammatory biomarkers in children with atopic dermatitis (AD): a case-control study

Abstract Background Atopic dermatitis is characterized by impaired skin barrier and altered cutaneous innate immunity. The estimated prevalence among Egyptian children was 10–12%. Several studies suggest that it may be associated with systemic comorbidities other than the spectrum of atopy, such as...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Amal Ahmed Mohamed, Eman Mohamed Salah, Nermeen Ibrahim Bedair, Dina M. Bassiouny, Aliaa E. M. Daifalla, Ola G. Behairy, Naglaa Fawazy, Mohamed F. Al Soda, Youssef M. K. Farag
Formato: article
Lenguaje:EN
Publicado: SpringerOpen 2021
Materias:
IgE
Acceso en línea:https://doaj.org/article/912a65bed4d6401bbe108793d062d6fc
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:912a65bed4d6401bbe108793d062d6fc
record_format dspace
spelling oai:doaj.org-article:912a65bed4d6401bbe108793d062d6fc2021-11-08T11:15:11ZMetabolic and inflammatory biomarkers in children with atopic dermatitis (AD): a case-control study10.1186/s43054-021-00083-x2090-9942https://doaj.org/article/912a65bed4d6401bbe108793d062d6fc2021-11-01T00:00:00Zhttps://doi.org/10.1186/s43054-021-00083-xhttps://doaj.org/toc/2090-9942Abstract Background Atopic dermatitis is characterized by impaired skin barrier and altered cutaneous innate immunity. The estimated prevalence among Egyptian children was 10–12%. Several studies suggest that it may be associated with systemic comorbidities other than the spectrum of atopy, such as metabolic syndrome and other inflammatory conditions. The aim of this study is to compare the profile of systemic conditions of diabetes, dyslipidemia, and multiple inflammatory markers in children with and without diagnosed atopic dermatitis. Methods One hundred atopic dermatitis patients and 101 normal controls were collected from outpatient clinic based on their clinical condition, both had measurement of body mass index, blood sugar, serum insulin, lipid profile, C reactive protein, and gamma-glutamyl transferase. Results Children diagnosed with atopic dermatitis had significantly higher levels of body mass index (34.7 ± 5.7 vs 26.1 ± 4.9), fasting glucose (143.2 ± 30.3 vs 100.8 ± 16.0), serum insulin (11.3 ± 4.4 vs. 4.6 ± 3.0), serum triglycerides (194.1 ± 38.1 vs 156.2 ± 31.6), total cholesterol (198.4 ± 27.7 vs 163.7 ± 27.7), alkaline phosphatase (229.4 ± 89.8 vs. 189.4 ± 46.8), and gamma-glutamyl transferase (54.7 ± 19.9 vs 34.3 ± 9.5), C-reactive protein level was approximately four times higher (19.9 ± 13.2 vs 5.1 ± 3.4) and the immunoglobulin E level was approximately 10 times higher (2050.3 ± 843.8 vs 252.7 ± 103.1) than in controls Conclusion We found a positive relationship of atopic dermatitis with both diabetes and hyperlipidemia among children, and positive dose-response relationship of several non-traditional biomarkers of C-reactive protein, gamma-glutamyl transferase, and alkaline phosphatase with the presence and severity of atopic dermatitis.Amal Ahmed MohamedEman Mohamed SalahNermeen Ibrahim BedairDina M. BassiounyAliaa E. M. DaifallaOla G. BehairyNaglaa FawazyMohamed F. Al SodaYoussef M. K. FaragSpringerOpenarticleAtopic dermatitisDiabetesDyslipidemiaC reactive proteinIgEGlutamyl gamma transferasePediatricsRJ1-570ENEgyptian Pediatric Association Gazette, Vol 69, Iss 1, Pp 1-5 (2021)
institution DOAJ
collection DOAJ
language EN
topic Atopic dermatitis
Diabetes
Dyslipidemia
C reactive protein
IgE
Glutamyl gamma transferase
Pediatrics
RJ1-570
spellingShingle Atopic dermatitis
Diabetes
Dyslipidemia
C reactive protein
IgE
Glutamyl gamma transferase
Pediatrics
RJ1-570
Amal Ahmed Mohamed
Eman Mohamed Salah
Nermeen Ibrahim Bedair
Dina M. Bassiouny
Aliaa E. M. Daifalla
Ola G. Behairy
Naglaa Fawazy
Mohamed F. Al Soda
Youssef M. K. Farag
Metabolic and inflammatory biomarkers in children with atopic dermatitis (AD): a case-control study
description Abstract Background Atopic dermatitis is characterized by impaired skin barrier and altered cutaneous innate immunity. The estimated prevalence among Egyptian children was 10–12%. Several studies suggest that it may be associated with systemic comorbidities other than the spectrum of atopy, such as metabolic syndrome and other inflammatory conditions. The aim of this study is to compare the profile of systemic conditions of diabetes, dyslipidemia, and multiple inflammatory markers in children with and without diagnosed atopic dermatitis. Methods One hundred atopic dermatitis patients and 101 normal controls were collected from outpatient clinic based on their clinical condition, both had measurement of body mass index, blood sugar, serum insulin, lipid profile, C reactive protein, and gamma-glutamyl transferase. Results Children diagnosed with atopic dermatitis had significantly higher levels of body mass index (34.7 ± 5.7 vs 26.1 ± 4.9), fasting glucose (143.2 ± 30.3 vs 100.8 ± 16.0), serum insulin (11.3 ± 4.4 vs. 4.6 ± 3.0), serum triglycerides (194.1 ± 38.1 vs 156.2 ± 31.6), total cholesterol (198.4 ± 27.7 vs 163.7 ± 27.7), alkaline phosphatase (229.4 ± 89.8 vs. 189.4 ± 46.8), and gamma-glutamyl transferase (54.7 ± 19.9 vs 34.3 ± 9.5), C-reactive protein level was approximately four times higher (19.9 ± 13.2 vs 5.1 ± 3.4) and the immunoglobulin E level was approximately 10 times higher (2050.3 ± 843.8 vs 252.7 ± 103.1) than in controls Conclusion We found a positive relationship of atopic dermatitis with both diabetes and hyperlipidemia among children, and positive dose-response relationship of several non-traditional biomarkers of C-reactive protein, gamma-glutamyl transferase, and alkaline phosphatase with the presence and severity of atopic dermatitis.
format article
author Amal Ahmed Mohamed
Eman Mohamed Salah
Nermeen Ibrahim Bedair
Dina M. Bassiouny
Aliaa E. M. Daifalla
Ola G. Behairy
Naglaa Fawazy
Mohamed F. Al Soda
Youssef M. K. Farag
author_facet Amal Ahmed Mohamed
Eman Mohamed Salah
Nermeen Ibrahim Bedair
Dina M. Bassiouny
Aliaa E. M. Daifalla
Ola G. Behairy
Naglaa Fawazy
Mohamed F. Al Soda
Youssef M. K. Farag
author_sort Amal Ahmed Mohamed
title Metabolic and inflammatory biomarkers in children with atopic dermatitis (AD): a case-control study
title_short Metabolic and inflammatory biomarkers in children with atopic dermatitis (AD): a case-control study
title_full Metabolic and inflammatory biomarkers in children with atopic dermatitis (AD): a case-control study
title_fullStr Metabolic and inflammatory biomarkers in children with atopic dermatitis (AD): a case-control study
title_full_unstemmed Metabolic and inflammatory biomarkers in children with atopic dermatitis (AD): a case-control study
title_sort metabolic and inflammatory biomarkers in children with atopic dermatitis (ad): a case-control study
publisher SpringerOpen
publishDate 2021
url https://doaj.org/article/912a65bed4d6401bbe108793d062d6fc
work_keys_str_mv AT amalahmedmohamed metabolicandinflammatorybiomarkersinchildrenwithatopicdermatitisadacasecontrolstudy
AT emanmohamedsalah metabolicandinflammatorybiomarkersinchildrenwithatopicdermatitisadacasecontrolstudy
AT nermeenibrahimbedair metabolicandinflammatorybiomarkersinchildrenwithatopicdermatitisadacasecontrolstudy
AT dinambassiouny metabolicandinflammatorybiomarkersinchildrenwithatopicdermatitisadacasecontrolstudy
AT aliaaemdaifalla metabolicandinflammatorybiomarkersinchildrenwithatopicdermatitisadacasecontrolstudy
AT olagbehairy metabolicandinflammatorybiomarkersinchildrenwithatopicdermatitisadacasecontrolstudy
AT naglaafawazy metabolicandinflammatorybiomarkersinchildrenwithatopicdermatitisadacasecontrolstudy
AT mohamedfalsoda metabolicandinflammatorybiomarkersinchildrenwithatopicdermatitisadacasecontrolstudy
AT youssefmkfarag metabolicandinflammatorybiomarkersinchildrenwithatopicdermatitisadacasecontrolstudy
_version_ 1718442357204975616